BTF3L4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.049600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.115800E-01
Normal-vs-Stage2
2.852200E-01
Normal-vs-Stage3
5.298100E-02
Normal-vs-Stage4
7.550400E-01
Stage1-vs-Stage2
8.499000E-01
Stage1-vs-Stage3
2.728200E-01
Stage1-vs-Stage4
2.535200E-01
Stage2-vs-Stage3
2.826600E-01
Stage2-vs-Stage4
9.620400E-02
Stage3-vs-Stage4
5.045600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.106600E-01
Normal-vs-AfricanAmerican
3.727200E-01
Normal-vs-Asian
2.519400E-01
Caucasian-vs-AfricanAmerican
9.252400E-01
Caucasian-vs-Asian
5.017800E-01
AfricanAmerican-vs-Asian
6.341000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.159600E-01
Normal-vs-Female
4.425000E-01
Male-vs-Female
1.007240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.923800E-01
Normal-vs-Age(41-60Yrs)
6.322800E-01
Normal-vs-Age(61-80Yrs)
2.166000E-01
Normal-vs-Age(81-100Yrs)
1.315760E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.206800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.659600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.261400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.475700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.719600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.567800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.211200E-01
Normal-vs-Daily Drinker
1.523180E-01
Normal-vs-Weekly Drinker
1.638600E-01
Normal-vs-Occasional Drinker
6.112400E-01
Normal-vs-Social Drinker
3.982800E-01
Non Drinker-vs-Daily Drinker
9.752000E-01
Non Drinker-vs-Weekly Drinker
7.648800E-01
Non Drinker-vs-Occasional Drinker
1.167360E-01
Non Drinker-vs-Social Drinker
3.680800E-01
Daily Drinker-vs-Weekly Drinker
7.718000E-01
Daily Drinker-vs-Occasional Drinker
9.576400E-02
Daily Drinker-vs-Social Drinker
3.241200E-01
Weekly Drinker-vs-Occasional Drinker
9.690000E-02
Weekly Drinker-vs-Social Drinker
2.758000E-01
Occasional Drinker-vs-Social Drinker
5.569600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.752000E-01
Normal-vs-Grade 2
8.938800E-01
Normal-vs-Grade 3
8.957000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.492160E-01
Grade 1-vs-Grade 3
2.926600E-01
Grade 1-vs-Grade 4
9.752000E-01
Grade 2-vs-Grade 3
9.754400E-01
Grade 2-vs-Grade 4
8.938800E-01
Grade 3-vs-Grade 4
8.957000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.445410E-01
Normal-vs-NonDiabetic
2.488400E-01
Diabetic-vs-NonDiabetic
4.378000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.302770E-01
Normal-vs-NoPancreatitis
2.590200E-01
Pancreatitis-vs-NoPancreatitis
5.613200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.766600E-01
Normal-vs-N1
2.962600E-01
N0-vs-N1
9.370800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.903000E-01
Normal-vs-TP53-NonMutant
3.431400E-01
TP53-Mutant-vs-TP53-NonMutant
1.721370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
